Moreover, inhibition of SIRT7 in endometrial and ovarian cancer cells leads to diminished cell proliferation, migration and higher sensitivity to anti-cancer drugs treatments [77, 79]. This evidence concerns the gene SIRT7 and ovarian carcinoma.